Autologous Platelet Concentrates and Photobiomodulation as Biologically Active Modifiers of Hard and Soft Tissue Healing: A Randomised Controlled Trial
Journal of Functional Biomaterials · 05.03.2026 · 17 (3) · 127
DOI: 10.3390/jfb17030127 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 05.03.2026. Verfasst von Daniel Selahi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Surgery, Faculty of Dentistry, Wroclaw Medical University, Krakowska 26, 50-425 Wroclaw, Poland. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Background/Objectives: This study evaluated autologous platelet concentrates (APCs), including advanced platelet-rich fibrin (A-PRF+) and concentrated growth factors (CGFs), as biologically active matrices, and photobiomodulation (PBM) as a biophysical stimulus affecting soft and hard tissue regeneration following mandibular third molar extraction.
Methods
A six-arm parallel randomised controlled trial was conducted including 135 patients. A total of 122 participants completed follow-up and were analysed: control (n = 22), photobiomodulation (n = 20), A-PRF+ (n = 19), CGF (n = 20), A-PRF+ plus photobiomodulation (n = 22), and CGF plus photobiomodulation (n = 19). The primary endpoint was postoperative pain intensity assessed on postoperative day 3 using an 11-point visual analogue scale (VAS). Secondary outcomes included swelling, trismus, wound healing assessed by the early healing index, and bone regeneration assessed by CBCT-based fractal dimension analysis at 4 months.
Results
On postoperative day 3, mean VAS pain was 2.95 ± 2.65 in the control group and 1.00 ± 1.65 in the photobiomodulation group, corresponding to a mean difference of 1.95 VAS points. The overall between-group difference for day 3 pain was statistically significant. In swelling outcomes, no statistically significant between-group differences were observed at days 1, 3, or 7 across facial measurement lines. In CBCT fractal analysis, a significant group effect was detected for the mid socket region, with higher fractal dimension at 4 months in the CGF plus photobiomodulation group compared with the control.
Conclusions
Both APCs and PBM positively influenced postoperative healing. Their combined application, particularly CGF with PBM, showed the most consistent regenerative effects, although not all outcomes differed significantly between groups. These minimally invasive strategies may support soft and hard tissue regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dental Surgery, Faculty of Dentistry, Wroclaw Medical University, Krakowska 26, 50-425 Wroclaw, Poland.
ORCID-Profile: Kamil Jurczyszyn, Jakub Hadzik
Förderung
- Wroclaw Medical University
Zitieren
APA
Selahi, D., Dominiak, M., Niemczyk, W., Pitułaj, A., Jurczyszyn, K., & Hadzik, J. (2026). Autologous Platelet Concentrates and Photobiomodulation as Biologically Active Modifiers of Hard and Soft Tissue Healing: A Randomised Controlled Trial. Journal of Functional Biomaterials, 17(3), 127. https://doi.org/10.3390/jfb17030127
Vancouver
Selahi D, Dominiak M, Niemczyk W, Pitułaj A, Jurczyszyn K, Hadzik J. Autologous Platelet Concentrates and Photobiomodulation as Biologically Active Modifiers of Hard and Soft Tissue Healing: A Randomised Controlled Trial. Journal of Functional Biomaterials. 2026;17(3):127. doi:10.3390/jfb17030127
BibTeX
@article{Selahi2026,
author = {Selahi, Daniel and Dominiak, Marzena and Niemczyk, Wojciech and Pitułaj, Artur and Jurczyszyn, Kamil and Hadzik, Jakub},
title = {Autologous Platelet Concentrates and Photobiomodulation as Biologically Active Modifiers of Hard and Soft Tissue Healing: A Randomised Controlled Trial},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {3},
pages = {127},
doi = {10.3390/jfb17030127}
}
EUVIMED